Search research articles
Contact Us
Filters
Showing results (1-10 of 196) with videos related to
Page
of 20
Sort By:
Neurosurgery Clinics of North America
|
November 23, 2020
Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era
Daniel P Cahill
Neurosurgery Clinics of North America
|
November 25, 2018
Extent of Resection Versus Molecular Classification: What Matters When?
Victoria E Clark, Daniel P Cahill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind
Philipp Karschnia, Joerg-Christian Tonn, Daniel P Cahill
Oncology (Williston Park, N.Y.)
|
August 6, 2013
Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management
Jennie W Taylor, Andrew S Chi, Daniel P Cahill
Neurosurgical Focus
|
February 5, 2013
From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
Gavin P Dunn, Ovidiu C Andronesi, Daniel P Cahill
CNS Oncology
|
November 7, 2015
Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1
Daniel P Cahill, David N Louis, John Gregory Cairncross
Expert Review of Anticancer Therapy
|
May 19, 2015
Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations
Tareq A Juratli, Daniel P Cahill, Ian E McCutcheon
Current Neurology and Neuroscience Reports
|
December 11, 2014
Systemic therapy of brain metastases
Harry C Brastianos, Daniel P Cahill, Priscilla K Brastianos
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 23, 2024
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
Yosuke Kitagawa, Ami Kobayashi, Daniel P Cahill, et al.
Pharmacology & Therapeutics
|
August 24, 2017
Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas
Tareq A Juratli, Nan Qin, Daniel P Cahill, et al.
Page
of 20
Search research articles
Search
Showing results (1-10 of 196) with videos related to
Sort By:
Page
of 20
Neurosurgery Clinics of North America
|
November 23, 2020
Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era
Daniel P Cahill
Neurosurgery Clinics of North America
|
November 25, 2018
Extent of Resection Versus Molecular Classification: What Matters When?
Victoria E Clark, Daniel P Cahill
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind
Philipp Karschnia, Joerg-Christian Tonn, Daniel P Cahill
Oncology (Williston Park, N.Y.)
|
August 6, 2013
Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management
Jennie W Taylor, Andrew S Chi, Daniel P Cahill
Neurosurgical Focus
|
February 5, 2013
From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
Gavin P Dunn, Ovidiu C Andronesi, Daniel P Cahill
CNS Oncology
|
November 7, 2015
Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1
Daniel P Cahill, David N Louis, John Gregory Cairncross
Expert Review of Anticancer Therapy
|
May 19, 2015
Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations
Tareq A Juratli, Daniel P Cahill, Ian E McCutcheon
Current Neurology and Neuroscience Reports
|
December 11, 2014
Systemic therapy of brain metastases
Harry C Brastianos, Daniel P Cahill, Priscilla K Brastianos
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 23, 2024
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
Yosuke Kitagawa, Ami Kobayashi, Daniel P Cahill, et al.
Pharmacology & Therapeutics
|
August 24, 2017
Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas
Tareq A Juratli, Nan Qin, Daniel P Cahill, et al.
Page
of 20